Please assess the completion status of the following clinical trial:

Trial Title: Bilateral Prefrontal Modulation in Alcoholism

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* patients between the age of 18 and 60 years;~* met criteria for alcohol dependence according to the Diagnostic and Statistical Manual of Mental Disorders, fourth edition (DSM-IV), as determined by clinical evaluation;~* in stable clinical condition with no need for inpatient care;~* able to read, write, and speak Portuguese; and~* no severe withdrawal signs or symptoms at baseline.~Exclusion Criteria:~* a condition of intoxication or withdrawal due to a substance other alcohol;~* unstable mental or medical disorder or substance abuse or addiction other than alcohol dependence, except nicotine and/or caffeine;~* a diagnosis of epilepsy, convulsions, or delirium tremens during abstinence from alcohol;~* a previous history of drug hypersensitivity or adverse reactions to diazepam or other benzodiazepines and haloperidol;~* any contraindication for electrical brain stimulation procedures such as electronic implants or metal implants;~* suspected pregnancy for female participants;~* any contraindication for magnetic resonance procedures such as electronic implants, metal implants, claustrophobia, or permanent make-up or tattoo received within the previous 3 months;~* the presence of vascular, traumatic, inflammatory, or tumor injuries detectable by CT examination.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 60 Years
- Healthy Volunteers: t

Study Arms:
- real tDCS (Type: EXPERIMENTAL): Ten sessions (every other day) of bilateral transcranial Direct Current Stimulation (tDCS: 2 milliamperes, 3 x 7 cm2, during 20 minutes) over dorsolateral Prefrontal Cortex (cathodal left / anodal right).
- sham-tDCS (Type: SHAM_COMPARATOR): Ten sessions (every other day) of placebo control (sham procedure) of transcranial Direct Current Stimulation (sham-tDCS) during 20 minutes with electrodes placed over the dorsolateral Prefrontal Cortex (cathodal left / anodal right). Current was delivered for 20 seconds and was turned off for the rest of the stimulation period. In this way, subjects experienced the initial itching sensation at the beginning of stimulation, but received no current for the rest of the session.

Based on this trial design, predict the completion outcome and termination type (if applicable).